SCHEMBL18089946

SCHEMBL18089946

c1ccc([Si](c2ccccc2)(c2nccc3c2oc2ccc(-c4cc5c(cn4)oc4ccccc45)cc23)c2nccc3c2oc2ccc(-c4cc5c(cn4)oc4ccccc45)cc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.38
MAPT P10636 3/20 0.38
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33
GABRG1 Q8N1C3 1/20 0.33
GABRG3 Q99928 1/20 0.33
GABRQ Q9UN88 1/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18090133 0.93 NPC1 (0.34) NPC1MAPTGABRPGABRDGABRA1
SCHEMBL18090100 0.91 NPC1 (0.34) NPC1MAPTPTPRFPTPN2PTPN1
SCHEMBL18090009 0.90 NPC1 (0.31) NPC1MAPT
SCHEMBL18089943 0.90 MAPT (0.43) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL18090058 0.86 NPC1 (0.31) NPC1MAPT
SCHEMBL18089921 0.84 NPC1 (0.36) NPC1MAPTGABRPGABRDGABRA1
SCHEMBL18089942 0.84 MAPT (0.38) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL18089917 0.83 ALOX5 (0.50) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL18089951 0.82 KDM4E (0.33) KDM4EPTPRFPTPN2PTPN1
SCHEMBL18090098 0.81 NPC1 (0.39) NPC1MAPTRAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780316-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-10-03 US disclosed
US-9780316-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-10-03 US disclosed
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-09-22 US disclosed
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160276604-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES RB1, LEF1, BRD1 NPC1 4402/4885MAPT 3821/4885GABRP 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.